Literature DB >> 21129852

When is electroconvulsive therapy appropriate for children and adolescents?

Lee E Wachtel1, Dirk M Dhossche, Charles H Kellner.   

Abstract

The indications for electroconvulsive therapy in children and adolescents are similar to those in adults, including severe affective, psychotic and catatonic pathology that has proven refractory to psychotropic medications and causes significant functional impairment. ECT may be indicated as well in specific pediatric neurological conditions. Multiple published reports demonstrate the safety and efficacy of ECT in pediatric patients with a wide range of psychopathology. ECT has also been successfully used in youth with autism and other neurodevelopmental disabilities who present with catatonic deterioration. However, resistance and stigma persist regarding the use of ECT in children and adolescents in both the professional and lay communities, creating barriers to pediatric ECT access. We argue that the use of ECT in children and adolescents is appropriate for specific clinical indications, and urge removal of impediments to ECT access in this population.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21129852     DOI: 10.1016/j.mehy.2010.11.001

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  10 in total

Review 1.  Pediatric Delirium: Evaluation, Management, and Special Considerations.

Authors:  Nasuh Malas; Khyati Brahmbhatt; Cristin McDermott; Allanceson Smith; Roberto Ortiz-Aguayo; Susan Turkel
Journal:  Curr Psychiatry Rep       Date:  2017-08-12       Impact factor: 5.285

2.  Autism-Like Behavior in BTBR Mice Is Improved by Electroconvulsive Therapy.

Authors:  Eunice Hagen; Dana Shprung; Elena Minakova; James Washington; Udaya Kumar; Don Shin; Raman Sankar; Andrey Mazarati
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

3.  Electroconvulsive therapy in adolescents with intellectual disability and severe self-injurious behavior and aggression: a retrospective study.

Authors:  Angele Consoli; Johan Cohen; Nicolas Bodeau; Vincent Guinchat; Lee Wachtel; David Cohen
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-08-25       Impact factor: 4.785

4.  Resignation Syndrome: Catatonia? Culture-Bound?

Authors:  Karl Sallin; Hugo Lagercrantz; Kathinka Evers; Ingemar Engström; Anders Hjern; Predrag Petrovic
Journal:  Front Behav Neurosci       Date:  2016-01-29       Impact factor: 3.558

5.  Electroconvulsive therapy for manic state with mixed and psychotic features in a teenager with bipolar disorder and comorbid episodic obsessive-compulsive disorder: a case report.

Authors:  Olof Rask; Klara Suneson; Eva Holmström; Beata Bäckström; Björn Axel Johansson
Journal:  J Med Case Rep       Date:  2017-12-12

6.  First known case of catatonia due to cyclosporine A-related neurotoxicity in a pediatric patient with steroid-resistant nephrotic syndrome.

Authors:  R David Heekin; Kalonda Bradshaw; Chadi A Calarge
Journal:  BMC Psychiatry       Date:  2019-04-24       Impact factor: 3.630

7.  Pervasive Refusal Syndrome: Three Case Reports-Autism as a Predisposing Factor and Gentle Coercion to Shorten Duration of Disorder?

Authors:  Håkan Jarbin; Ann-Sofie Saldeen; Carl-Magnus Forslund
Journal:  Case Rep Psychiatry       Date:  2022-03-23

8.  Catatonia with Psychosis in an 8-Year-Old Child: A Case Report and a Literature Review.

Authors:  Margaret D Weiss; Larry Schibuk; Srinivasa B Gokarakonda; Renea Henderson; Dianna Esmaeilpour
Journal:  Case Rep Psychiatry       Date:  2022-03-25

Review 9.  Depression in Adolescence and Brain-Derived Neurotrophic Factor.

Authors:  Boyoung Lee; Eunjin Shin; Inwoong Song; Bomi Chang
Journal:  Front Mol Neurosci       Date:  2022-07-07       Impact factor: 6.261

10.  Electroconvulsive therapy use in adolescents: a systematic review.

Authors:  Nádia Nr Lima; Vânia B Nascimento; Jorge Ac Peixoto; Marcial M Moreira; Modesto Lr Neto; José C Almeida; Carlos Ac Vasconcelos; Saulo A Teixeira; Jucier G Júnior; Francisco Tc Junior; Diego Dm Guimarães; Aline Q Brasil; Jesus S Cartaxo; Marco Akerman; Alberto Oa Reis
Journal:  Ann Gen Psychiatry       Date:  2013-05-30       Impact factor: 3.455

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.